Thailand - Delayed Quote THB
DOD Biotech Public Company Limited (DOD.BK)
1.7800
-0.2100
(-10.55%)
At close: June 13 at 4:39:50 PM GMT+7
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
647,110.8140
645,384.8140
663,614.5780
537,158.7780
1,015,317.1920
Cost of Revenue
442,014.9830
438,576.9830
406,356.8890
396,656.9920
580,695.9550
Gross Profit
205,095.8310
206,807.8310
257,257.6890
140,501.7860
434,621.2370
Operating Expense
175,639.8140
192,347.8140
169,421.2030
151,879.0810
123,814.8440
Operating Income
29,456.0170
14,460.0170
87,836.4860
-11,377.2950
310,806.3930
Net Non Operating Interest Income Expense
-2,045.2340
-3,002.2340
-5,058.6800
-6,986.8590
-6,462.5860
Other Income Expense
13,629
29,034
10,039
-405,861
-39,282.7820
Pretax Income
41,040.1940
40,492.1940
92,816.8000
-424,225.5060
265,061.0250
Tax Provision
11,321.7040
13,317.7040
28,303.7610
-79,107.1760
31,956.9040
Net Income Common Stockholders
-132,388.2570
-159,333.2570
7,186.7530
-398,334.0430
49,789.5350
Diluted NI Available to Com Stockholders
-132,388.2570
-159,333.2570
7,186.7530
-398,334.0430
49,789.5350
Basic EPS
-0.29
-0.35
0.02
-0.97
0.12
Diluted EPS
-0.29
-0.35
0.02
-0.97
0.12
Basic Average Shares
450,414
450,414
435,309
410,000
411,212.7140
Diluted Average Shares
450,414.2850
450,414
435,309
410,000
411,212.7140
Total Operating Income as Reported
43,085.4280
43,494.4280
97,875.4800
-417,238.6470
271,523.6110
Total Expenses
617,654.7970
630,924.7970
575,778.0920
548,536.0730
704,510.7990
Net Income from Continuing & Discontinued Operation
-132,388.2570
-159,333.2570
7,186.7530
-398,334.0430
49,789.5350
Normalized Income
46,109.0562
39,461.3965
58,350.1019
-8,125.1497
298,043.3098
Interest Income
997.0750
732.0750
248.9880
107.9360
252.4710
Interest Expense
3,042.3090
3,734.3090
5,307.6680
7,094.7950
6,715.0570
Net Interest Income
-2,045.2340
-3,002.2340
-5,058.6800
-6,986.8590
-6,462.5860
EBIT
44,082.5030
44,226.5030
98,124.4680
-417,130.7110
271,776.0820
EBITDA
96,392.0200
104,893.0200
171,590.9310
-352,628.6060
338,819.1100
Reconciled Cost of Revenue
442,014.9830
438,576.9830
406,356.8890
396,656.9920
580,695.9550
Reconciled Depreciation
52,309.5170
60,666.5170
73,466.4630
64,502.1050
67,043.0280
Net Income from Continuing Operation Net Minority Interest
55,978.2420
58,946.2420
65,327.7870
-338,303.4830
263,496.6300
Total Unusual Items Excluding Goodwill
13,629
29,034
10,039
-405,861
-39,282.7820
Total Unusual Items
13,629
29,034
10,039
-405,861
-39,282.7820
Normalized EBITDA
82,763.0200
75,859.0200
161,551.9310
53,232.3940
378,101.8920
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0002
0.0001
Tax Effect of Unusual Items
3,759.8142
9,549.1545
3,061.3149
-75,682.6667
-4,736.1022
12/31/2021 - 6/20/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade